Literature DB >> 2943596

Multiple pathways for antigen-independent activation of a T helper hybridoma.

B E Torbett, B Skidmore, W R Clark.   

Abstract

An important question in mitogen activation of T cells is whether the T cell must interact with a major histocompatibility complex product during the activation process. The T helper hybridoma AODH 7.1 is specific for human gamma globulin in the context of IEd, and when activated secretes interleukin 2. The mitogen concanavalin A (Con A) can activate AODH 7.1 cells directly, but two other standard T cell mitogens, phytohemagglutinin (PHA) and neuraminidase-galactose oxidase, cannot. However, Con A, PHA and neuraminidase-galactose oxidase could all activate AODH 7.1 when presented on various cloned class II+ cell lines. There was an absolute requirement for the presentor cell to be class II+, and the activation signal on mitogen-treated class II+ presentor could be blocked by monoclonal antibody to the class II antigens. To determine if class II molecules were absolutely required for the presentation of a mitogen activation signal we used class II- LtK- L cells and two LtK- cell class II gene transformants as presentor cells. Only the class II+ transformants, but not the class II- LtK- cells, could present either Con A or PHA. The class II requirement cannot be bypassed through provision of soluble factors. However, when Con A was used to activate AODH 7.1 cells directly, it appeared to be acting in a transmembrane fashion. It was not the case that AODH 7.1 cells were responding to Con A on a neighboring AODH 7.1 cell, and no class II antigens were involved. These results are consistent with the idea that different routes of activation exist for T cells, at least at the level of signal recognition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943596     DOI: 10.1002/eji.1830160810

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  1 in total

1.  Suppression of bovine lymphocyte responses to mitogens following in vivo and in vitro treatment with dexamethasone.

Authors:  G Oldham; C J Howard
Journal:  Vet Immunol Immunopathol       Date:  1992-01-15       Impact factor: 2.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.